Researchers at Umeå University have discovered that the SARS-CoV-2 variant omicron has developed a stronger binding to human ...

New research delves into the DNA details and chromatin structures that may predict prognosis in early-stage lung ...

This paper explores the potential of mitochondrial-associated programmed-cell-death (mtPCD) patterns as biomarkers for ...

The study in the European Respiratory Journal used advanced spatial mapping techniques to compare healthy lung tissues and ...

Subcutaneous pembrolizumab reduces time demands for both the patient and clinician, all while providing a consistent efficacy ...

Rutgers Health researchers have discovered that networks of misplaced immune cells drive an aggressive lung disease, ...

Researchers have identified networks of misplaced immune cells, particularly plasma cells, driving idiopathic pulmonary fibrosis (IPF), a fatal lung disease. These cells, typically found in bone ...

This week Bobbi Conner talks with Dr. Miriam Alexander about advances in lung cancer treatment in recent years. Dr. Alexander ...

Small-cell lung cancer (SCLC) is the most aggressive type of lung cancer. Each year in the U.S., about 30,000 to 35,000 people are diagnosed with it. For most, it has already spread to distant ...

BioNTech has shown why it made small cell lung cancer (SCLC) a priority for its PD-L1xVEGF-A bispecific. | BioNTech has shown ...

Using real world data from 1,600 patients, available ... Mar. 13, 2025 — A discovery about how severe COVID-19 damages lung cells suggests that an existing drug could treat lingering respiratory ...

Feb. 12, 2025 — Researchers have found that some particularly aggressive lung cancer cells can develop their own electric network, like that seen in the body's nervous ... Feb. 6, 2025 ...